Anti–PD-1 Therapy in Melanoma - ScienceDirect
PD-1
News
Schematic representation of PD-1 and anti-PD-1/PD-L1 mechanisms of... | Download Scientific Diagram
Efficacy of anti-PD-1 therapy. HCC was induced by HDI of MET/β-catenin.... | Download Scientific Diagram
The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer: Molecular Therapy
Biomarkers of response to PD-1 pathway blockade | British Journal of Cancer
PD1 Antibody Selection Tool | Bio X Cell
Emerging Role of Ubiquitination in the Regulation of PD-1/PD-L1 in Cancer Immunotherapy: Molecular Therapy
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics | Journal of Hematology & Oncology | Full Text
Anti–PD-1 antibodies recognizing the membrane-proximal region are PD-1 agonists that can down-regulate inflammatory diseases | Science Immunology
Advancing Precision Medicine: In Vitro Potency Assays for Evaluating the Function of anti-PD-1 Checkpoint Inhibitors
Current issues and perspectives in PD-1 blockade cancer immunotherapy | International Journal of Clinical Oncology
PD-1: Expanding Beyond Cancer Research | ProSci
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma | NEJM
Anti-PD-1 Inhibitors – Melanoma Unit
PD-1
Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
Frontiers | Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer
Biomolecules | Free Full-Text | The Emerging Role of IL-9 in the Anticancer Effects of Anti-PD-1 Therapy
Anti-hPD-1 antibodies | Pembrolizumab & Nivolumab biosimilar isotypes | InvivoGen
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study - The Lancet Oncology
Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles | Nature Communications
